ARS Wealth Advisors Group LLC Makes New Investment in Danaher Corporation $DHR

ARS Wealth Advisors Group LLC bought a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 111,582 shares of the conglomerate's stock, valued at approximately $24,721,000. Danaher makes up approximately 1.6% of ARS Wealth Advisors Group LLC's portfolio, making the stock its 19th biggest position.

A number of other institutional investors have also recently modified their holdings of the business. Veery Capital LLC raised its holdings in Danaher by 3.1% in the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate's stock worth $350,000 after purchasing an additional 48 shares during the period. Studio Investment Management LLC lifted its position in shares of Danaher by 3.3% during the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate's stock valued at $302,000 after buying an additional 51 shares in the last quarter. JDH Wealth Management LLC lifted its position in shares of Danaher by 4.5% during the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate's stock valued at $240,000 after buying an additional 55 shares in the last quarter. OLD Second National Bank of Aurora lifted its position in shares of Danaher by 0.5% during the 1st quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate's stock valued at $2,297,000 after buying an additional 57 shares in the last quarter. Finally, Adelphi Trust Co grew its stake in Danaher by 2.5% in the 3rd quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate's stock valued at $524,000 after acquiring an additional 57 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

NYSE:DHR opened at $228.87 on Friday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a market cap of $160.89 billion, a PE ratio of 40.65, a P/E/G ratio of 2.91 and a beta of 0.76. The stock has a 50 day moving average price of $214.04 and a 200 day moving average price of $195.97.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the previous year, the company posted $0.77 earnings per share. The firm's revenue for the quarter was up 5.5% compared to the same quarter last year. Equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's dividend payout ratio is currently 28.42%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on DHR shares. Evercore reissued an "outperform" rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Royal Bank Of Canada boosted their target price on shares of Danaher from $215.00 to $250.00 and gave the stock an "outperform" rating in a research note on Monday, October 5th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Weiss Ratings raised shares of Danaher from a "hold (c-)" rating to a "hold (c)" rating in a research note on Wednesday, September 16th. Finally, Guggenheim boosted their price objective on Danaher from $200.00 to $250.00 and gave the stock a "buy" rating in a research note on Thursday, October 1st. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $235.41.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.